Search Results - "BERTOLI, A"

Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals by Armenia, D., Gagliardini, R., Alteri, C., Svicher, V., Cento, V., Borghi, V., Vergori, A., Cicalini, S., Forbici, F., Fabeni, L., Bertoli, A., Brugneti, M., Gennari, W., Malagnino, V., Andreoni, M., Mussini, C., Antinori, A., Perno, C.F., Santoro, M.M., Ceccherini-Silberstein, F.

“…•In the last decade, resistance in HIV-DNA was 35% in Italy.•Resistance in HIV-DNA was stable over the period 2010-2021.•Complex treatment history was…”
Get full text

HIV MDR is still a relevant issue despite its dramatic drop over the years by Armenia, D, Di Carlo, D, Flandre, P, Bouba, Y, Borghi, V, Forbici, F, Bertoli, A, Gori, C, Fabeni, L, Gennari, W, Pinnetti, C, Mondi, A, Cicalini, S, Gagliardini, R, Vergori, A, Bellagamba, R, Malagnino, V, Montella, F, Colafigli, M, Latini, A, Marocco, R, Licthner, M, Andreoni, M, Mussini, C, Ceccherini-Silberstein, F, Antinori, A, Perno, C F, Santoro, M M

“…Abstract Objectives To evaluate the prevalence and therapeutic relevance of drug resistance among isolates from ART-experienced HIV-1-infected patients over…”
Get full text

Aroma characterisation and UV elicitation of purple basil from different plant tissue cultures by Bertoli, A., Lucchesini, M., Mensuali-Sodi, A., Leonardi, M., Doveri, S., Magnabosco, A., Pistelli, L.

“…•Volatile fingerprint analysis of two purple basil cultivars was performed.•In vitro biomass was established and compared with in vivo young plants.•UV…”
Get full text

Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability by Bertoli, A M, Fernández, M, Alarcón, G S, Vilá, L M, Reveille, J D

“…Objective: To examine the risk factors for self-reported work disability in patients from the LUpus in MInorities: NAture vs. Nurture cohort with systemic…”
Get full text

HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia by Armenia, D, Fabeni, L, Alteri, C, Di Pinto, D, Di Carlo, D, Bertoli, A, Gori, C, Carta, S, Fedele, V, Forbici, F, D'Arrigo, R, Svicher, V, Berno, G, Pizzi, D, Nicastri, E, Sarmati, L, Pinnetti, C, Ammassari, A, D'Offizi, G, Latini, A, Andreoni, M, Antinori, A, Ceccherini-Silberstein, F, Perno, C F, Santoro, M M

“…Integrase drug resistance monitoring deserves attention because of the increasing number of patients being treated with integrase strand-transfer inhibitors…”
Get full text

Establishment of in vitro tissue cultures from Echinacea angustifolia D.C. adult plants for the production of phytochemical compounds by Lucchesini, M., Bertoli, A., Mensuali-Sodi, A., Pistelli, L.

“…The establishment of in vitro cultures of Echinacea angustifolia D.C. was obtained directly from sections of flower stalks of adult plants. The shoot formation…”
Get full text

A founder nonsense variant in NUDT2 causes a recessive neurodevelopmental disorder in Saudi Arab children by Yavuz, H., Bertoli‐Avella, A.M., Alfadhel, M., Al‐Sannaa, N., Kandaswamy, K.K., Al‐Tuwaijri, W., Rolfs, A., Brandau, O., Bauer, P.

“…We identified the homozygous p.Arg12* variant in 5 patients with neurodevelopmental delay, but variation databases list many truncating heterozygous variants…”
Get full text

Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen by Armenia, D, Di Carlo, D, Calcagno, A, Vendemiati, G, Forbici, F, Bertoli, A, Berno, G, Carta, S, Continenza, F, Fedele, V, Bellagamba, R, Cicalini, S, Ammassari, A, Libertone, R, Zaccarelli, M, Ghisetti, V, Andreoni, M, Ceccherini-Silberstein, F, Bonora, S, Di Perri, G, Antinori, A, Perno, C F, Santoro, M M

“…To evaluate the maintenance of virological suppression (VS) in antiretroviral-treated HIV-1-suppressed patients switching to a…”
Get full text

Frailty and nutritional status in older people: the Mini Nutritional Assessment as a screening tool for the identification of frail subjects [Corrigendum] by A, Valentini, M, Federici, MA, Cianfarani, U, Tarantino, A., Bertoli

“…Valentini A, Federici M, Cianfarani MA, Tarantino U, Bertoli A. Clin Interv Aging. 2018;13:1237-1244. Page 1238, Patients and methods, the first two paragraphs…”
Get full text

Recurrent Bell's palsy: outcomes and correlation with clinical comorbidities by Mancini, P, Bottaro, V, Capitani, F, De Soccio, G, Prosperini, L, Restaino, P, De Vincentiis, M, Greco, A, Bertoli, G A, De Seta, D

“…Recurrent Bell’s palsy (RBP) has been reported to range from 2.6 to 15.2% of primary Bell’s palsy (BP) and has been associated with systemic comorbidities such…”
Get full text

Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome by Di Renzo, L, Bertoli, A, Bigioni, M, Del Gobbo, V, Premrov, M G, Calabrese, V, Di Daniele, N, De Lorenzo, A

“…Insulin resistance and obesity are intimately related to a chronic low grade systemic inflammation. Interleukin-6 (IL-6) may influence the pathogenesis of…”
Get more information

The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor by Goldwurm, S, Fonzo, A Di, Simons, E J, Rohé, C F, Zini, M, Canesi, M, Tesei, S, Zecchinelli, A, Antonini, A, Mariani, C, Meucci, N, Sacilotto, G, Sironi, F, Salani, G, Ferreira, J, Chien, H F, Fabrizio, E, Vanacore, N, Libera, A Dalla, Stocchi, F, Diroma, C, Lamberti, P, Sampaio, C, Meco, G, Barbosa, E, Bertoli-Avella, A M, Breedveld, G J, Oostra, B A, Pezzoli, G, Bonifati, V

“…Background: Mutations in the gene Leucine-Rich Repeat Kinase 2 (LRRK2) were recently identified as the cause of PARK8 linked autosomal dominant Parkinson’s…”
Get full text

Expanding the clinical and genetic spectra of NKX6‐2‐related disorder by Baldi, C., Bertoli‐Avella, A.M., Al‐Sannaa, N., Alfadhel, M., Al‐Thihli, K., Alameer, S., Elmonairy, A.A., Al Shamsi, A.M., Abdelrahman, H.A., Al‐Gazali, L., Shawli, A., Al‐Hakami, F., Yavuz, H., Kandaswamy, K.K., Rolfs, A., Brandau, O., Bauer, P.

“…Hypomyelinating leukodystrophies (HLDs) affect the white matter of the central nervous system and manifest as neurological disorders. They are genetically…”
Get full text

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) by Alarcón, Graciela S, McGwin, Gerald, Bertoli, Ana M, Fessler, Barri J, Calvo-Alén, Jaime, Bastian, Holly M, Vilá, Luis M, Reveille, John D

“…Objective: In patients with systemic lupus erythematosus (SLE), hydroxychloroquine prevents disease flares and damage accrual and facilitates the response to…”
Get full text

Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort : LUMINA (LUI) by ANDRADE, R, SANCHEZ, M. L, ALARCON, G. S, FESSLER, B. J, FERNANDEZ, M, BERTOLI, A. M, APTE, M, VILA, L. M, ARANGO, A. M, REVEILLE, J. D

“…To study the factors associated with an adverse pregnancy outcome in women with systemic lupus erythematosus (SLE). SLE women from LUMINA of Hispanic, African…”
Get full text

Virological response and resistance profile in HIV‐1‐infected patients starting darunavir‐containing regimens by Armenia, D, Di Carlo, D, Maffongelli, G, Borghi, V, Alteri, C, Forbici, F, Bertoli, A, Gori, C, Giuliani, M, Nicastri, E, Zaccarelli, M, Pinnetti, C, Cicalini, S, D'Offizi, G, Ceccherini‐Silberstein, F, Mussini, C, Antinori, A, Andreoni, M, Perno, CF, Santoro, MM

“…Objectives We evaluated the virological response in patients starting a regimen based on darunavir/ritonavir (DRV/r), which is currently the most widely used…”
Get full text

Spanish LupusPRO: cross-cultural validation study for lupus by Jolly, M, Toloza, S, Block, J, Mikolaitis, R, Kosinski, M, Wallace, D, Durran-Barragan, S, Bertoli, A, Blazevic, I, Vilá, L, Cooray, D, Moldovan, I, Katsaros, E, Weisman, M, Torralba, KM, Alarcón, G

“…Purpose LupusPRO is a disease-targeted, patient-reported, outcome measure that was developed and validated among US patients with systemic lupus erythematosus…”
Get full text

Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus by Bertoli, A M, Vilá, L M, Reveille, J D, Alarcón, G S

“…To determine the features associated with acute onset systemic lupus erythaematosus (SLE). A total of 631 SLE patients from LUMINA (for "lupus in minority…”
Get more information

Gain of positively charged amino acids at specific positions of HBsAg C-terminus tightly correlates with HBV-induced hepatocellular carcinoma by altering the structural folding of this domain by Salpini, R, Carioti, L, Aragri, M, Di Carlo, D, Colagrossi, L, Battisti, A, Piermatteo, L, Bertoli, A, Fabeni, L, Ricciardi, A, Longo, R, Romano, S, Cappiello, G, Spanò, A, Trimoulet, P, Fleury, H, Vecchiet, J, Iapadre, N, Barlattani, A, Mari, T, Pasquazzi, C, Lenci, I, Francioso, S, Parruti, G, Sarmati, L, Andreoni, M, Angelico, M, Ceccherini-Silberstein, F, Perno, C.F, Svicher, V

Get full text

The circulation of specific vaccine-escape HBsAg mutations in HBV genotype D infected patients correlates with high viremia and affects HBsAg detection and quantification by Salpini, R, Piermatteo, L, Di Carlo, D, Battisti, A, Colagrossi, L, Bertoli, A, Fabeni, L, Fini, V, Iuvara, A, Ricciardi, A, Cerva, C, Sarrecchia, C, Lichtner, M, Mastroianni, C, De Sanctis, G, Paoloni, M, Marignani, M, Pasquazzi, C, Iapadre, N, Mari, T, Parruti, G, Romano, S, Visca, M, Moretti, A, Vecchiet, J, Sarmati, L, Andreoni, M, Cappiello, G, Spanò, A, Grelli, S, Angelico, M, Perno, C.F, Svicher, V

Get full text